Atypical Multifocal Granular Cell Tumor with FLT3 Y842C Somatic Mutation: A case report and a review of the literature

##plugins.themes.academic_pro.article.main##

Alexandra Zara Rozalen
Ruth Garcia
Samir Husami
Gustavo Marino
Victor E Nava

Abstract

Introduction. Granular cell tumors (GCT) are predominantly benign neoplasms composed by cells with abundant eosinophilic granular cytoplasm. Although the majority of GCTs exhibit a benign clinical course, a minority display cytological atypia and may exhibit aggressive, cancer-like behavior. Definitive evidence of malignancy in GCTs is reliably established only through the presence of metastasis. Addi- tionally, a subset of GCTs demonstrates a high rate of recurrence, underscoring the need for better prog- nostic markers. Therefore, it is crucial to identify molecular markers associated with aggressive behavior in GCTs. Molecular analysis may be particularly beneficial in cases exhibiting cytological atypia to in- form clinical outcome prognostication and guide therapeutic strategies.


Observation. In this case report, a 45-year-old female with multiple gastrointestinal GCTs is pre- sented. The patient did not have any genetic syndromes commonly associated with GCT, such as neu- rofibromatosis type 1, Noonan syndrome or LEOPARD syndrome. The tumors not only demonstrated nuclear atypia, but also harbored a unique FLT3 Y842C somatic alteration identified by next-genera- tion sequencing. The patient remains asymptomatic and under endoscopic surveillance two years after diagnosis and complete resection of the neoplasms.


Conclusion. We presented an exceedingly rare case of multifocal atypical GCT in an adult without any previously known genetic syndrome. A tumoral FLT3 Y842C point mutation not previously reported in GCT was discovered. Although the precise significance of this finding is uncertain, FLT3 Y842C has been cataloged as likely pathogenic in ClinVar. This report underscores the potential predictive utility of next-generation sequencing in the characterization ....(abstract truncated at 250 words)

Keywords:

Case Report, Endoscopy, Immunohistochemistry, Next-Generation Sequencing

##plugins.themes.academic_pro.article.details##

Author Biographies

Alexandra Zara Rozalen, Mount Sinai West, Department of Pathology, 10019, New York, NY. Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.

Mount Sinai West, Department of Pathology, 10019, New York, NY, USA

Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.

Ruth Garcia, Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.

Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.

Samir Husami, Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.

Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.

Gustavo Marino, Washington DC VA Medical Center, Division of Gastroenterology, 20422, Washington DC, USA.

Washington DC VA Medical Center, Division of Gastroenterology, 20422, Washington DC, USA.

Victor E Nava, Washington DC VA Medical Center, Department of Pathology, 20422, Washington. The George Washington University Hospital, Department of Pathology, 20037, Washington, DC, USA.

Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.

The George Washington University Hospital, Department of Pathology, 20037, Washington, DC, USA

References

  1. Nasser H, Ahmed Y, Szpunar SM, Kowalski PJ. Malignant granular cell tumor: a look
  2. into the diagnostic criteria. Pathol Res Pract. 2011;207(3):164-8.
  3. Stemm M, Suster D, Wakely PE, Jr., Suster S. Typical and Atypical Granular Cell Tumors
  4. of Soft Tissue: A Clinicopathologic Study of 50 Patients. Am J Clin Pathol. 2017;148(2):161-6.
  5. Movahed S, Amiri AJ, Kalkali AR. A case report of atypical granular cell tumor of bladder.
  6. Int J Surg Case Rep. 2024;121:109980.
  7. Warren SJ, Alomari AK. Utility of sequencing for ATP6AP1 and ATP6AP2 to distinguish between atypical granular cell tumor with junctional component and melanoma. J Cutan Pathol.
  8. ;50(11):1014-9.
  9. Liu JP, Song LX, Xu ZY, Wu Y, Yao XC, Li M, et al. Case report: Giant atypical granular
  10. cell tumor of the median nerve. Front Neurol. 2023;14:1221912.
  11. Wei MZ, Yan ZJ, Jiang JH, Jia XL. Atypical granular cell tumor of the urinary bladder: A
  12. case report. World J Clin Cases. 2021;9(28):8453-60.
  13. Tufano A, Canale V, Di Lascio G, Coppola G, Flammia RS, Cristini C. Atypical granular
  14. cell tumor of the urinary bladder: A case report and literature review. Urol Case Rep.
  15. ;38:101669.
  16. Brunsgaard EK, Wallis L, Cody B, Cavanaugh K. Atypical granular cell tumor developing
  17. within a tattoo. JAAD Case Rep. 2020;6(6):546-8.
  18. Nakamura Y, Fujino T, Nagata K, Imamura T, Teramoto Y, Asami Y, et al. A Rare Case
  19. of a Primary Cutaneous Desmoplastic Atypical Granular Cell Tumor. Am J Dermatopathol.
  20. ;39(4):e50-e3.
  21. Oh KY, Kang KR, Yoon HJ, Lee JI, Hong SP, Hong SD. Atypical granular cell tumor in
  22. the maxilla: The first report of primary intraosseous granular cell tumor. Head Neck.
  23. ;38(8):E2467-70.
  24. Mahoney A, Garg A, Wolpowitz D, Mahalingam M. Atypical granular cell tumor-apropos
  25. of a case with indeterminate malignant potential. Am J Dermatopathol. 2010;32(4):370-3.
  26. Ayadi L, Khabir A, Fakhfakh I, Abdelmoula MH, Makni S, Sellami Boudawara T.
  27. [Granular cell tumor]. Rev Stomatol Chir Maxillofac. 2008;109(3):158-62.
  28. Fanburg-Smith JC, Meis-Kindblom JM, Fante R, Kindblom LG. Malignant granular cell
  29. tumor of soft tissue: diagnostic criteria and clinicopathologic correlation. Am J Surg Pathol.
  30. ;22(7):779-94.
  31. Schrader KA, Nelson TN, De Luca A, Huntsman DG, McGillivray BC. Multiple granular
  32. cell tumors are an associated feature of LEOPARD syndrome caused by mutation in PTPN11.
  33. Clin Genet. 2009;75(2):185-9.
  34. Ramaswamy PV, Storm CA, Filiano JJ, Dinulos JG. Multiple granular cell tumors in a
  35. child with Noonan syndrome. Pediatr Dermatol. 2010;27(2):209-11.
  36. Pareja F, Brandes AH, Basili T, Selenica P, Geyer FC, Fan D, et al. Loss-of-function
  37. mutations in ATP6AP1 and ATP6AP2 in granular cell tumors. Nat Commun. 2018;9(1):3533.
  38. Wei L, Liu S, Conroy J, Wang J, Papanicolau-Sengos A, Glenn ST, et al. Whole-genome
  39. sequencing of a malignant granular cell tumor with metabolic response to pazopanib. Cold
  40. Spring Harb Mol Case Stud. 2015;1(1):a000380.
  41. Kindler T, Breitenbuecher F, Kasper S, Estey E, Giles F, Feldman E, et al. Identification
  42. of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute
  43. myeloid leukemia (AML). Blood. 2005;105(1):335-40.
  44. Cheng J, Qu L, Wang J, Cheng L, Wang Y. High expression of FLT3 is a risk factor in
  45. leukemia. Mol Med Rep. 2018;17(2):2885-92.
  46. AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov. 2017;7(8):818-31.